Marcio Andrade‐Campos

Also affiliated with Fundación Española para la Ciencia y la Tecnología, Parc de Salut

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “A Phase 1 First-in-Human Study of the MCL-1 Inhibitor AZD5991 in Patients with Relapsed/Refractory Hematologic Malignancies”.

A Phase 1 First-in-Human Study of the MCL-1 Inhibitor AZD5991 in Patients with Relapsed/Refractory Hematologic Malignancies

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0028

N/A

0DataRank · unranked

47 citations

Sagar Lonial, Amanda F. Cashen, Manali Kamdar, Ian W. Flinn, Susan O’Brien +15 more

Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study

Blood Advances(2024)10.1182/bloodadvances.2024013451

N/A

0DataRank · unranked

14 citations

Noel Estrada‐Merly, María Queralt Salas, Soyoung Kim, Jakob D. DeVos, Min Chen +59 more